Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.

J Clin Invest 2016 Jan 23;126(1):68-84. Epub 2015 Nov 23.

MDM4 is a promising target for cancer therapy, as it is undetectable in most normal adult tissues but often upregulated in cancer cells to dampen p53 tumor-suppressor function. The mechanisms that underlie MDM4 upregulation in cancer cells are largely unknown. Here, we have shown that this key oncogenic event mainly depends on a specific alternative splicing switch. We determined that while a nonsense-mediated, decay-targeted isoform of MDM4 (MDM4-S) is produced in normal adult tissues as a result of exon 6 skipping, enhanced exon 6 inclusion leads to expression of full-length MDM4 in a large number of human cancers. Although this alternative splicing event is likely regulated by multiple splicing factors, we identified the SRSF3 oncoprotein as a key enhancer of exon 6 inclusion. In multiple human melanoma cell lines and in melanoma patient-derived xenograft (PDX) mouse models, antisense oligonucleotide-mediated (ASO-mediated) skipping of exon 6 decreased MDM4 abundance, inhibited melanoma growth, and enhanced sensitivity to MAPK-targeting therapeutics. Additionally, ASO-based MDM4 targeting reduced diffuse large B cell lymphoma PDX growth. As full-length MDM4 is enhanced in multiple human tumors, our data indicate that this strategy is applicable to a wide range of tumor types. We conclude that enhanced MDM4 exon 6 inclusion is a common oncogenic event and has potential as a clinically compatible therapeutic target.

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI82534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701541PMC
January 2016
46 Reads
13.215 Impact Factor

Publication Analysis

Top Keywords

exon inclusion
12
mdm4
9
adult tissues
8
alternative splicing
8
cancer cells
8
full-length mdm4
8
exon skipping
8
normal adult
8
multiple human
8
mdm4 exon
8
oncogenic event
8
antisense oligonucleotide-mediated
8
exon
6
data indicate
4
multiple splicing
4
factors identified
4
splicing factors
4
oncoprotein key
4
key enhancer
4
enhancer exon
4

Similar Publications